H&R GmbH & Co. KGaA (ETR:2HRA)

Market Cap	183.88M
Revenue (ttm)	1.36B
Net Income (ttm)	11.05M
Shares Out	37.22M
EPS (ttm)	0.29
PE Ratio	16.77
Forward PE	15.32
Dividend	0.10 (2.01%)
Ex-Dividend Date	May 28, 2025

Volume	4,441
Average Volume	35,029
Open	4.920
Previous Close	4.940
Day's Range	4.920 - 4.960
52-Week Range	3.230 - 5.040
Beta	0.77
RSI	62.62
Earnings Date	Aug 15, 2025

About H&R GmbH & Co. KGaA

H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts in Europe, Africa, Asia, and internationally. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as by-products, such as feedstocks and bunker fuels. The ChemPharm Sales segment processes and distributes...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2016
• Employees: 1,705
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: 2HRA

Financial Performance

In 2024, H&R GmbH & Co. KGaA's revenue was 1.35 billion, a decrease of -1.06% compared to the previous year's 1.36 billion. Earnings were 10.62 million, an increase of 0.63%.